Tan et al., 1985 - Google Patents
A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells.Tan et al., 1985
- Document ID
- 18334946305121743157
- Author
- Tan L
- Oi V
- Morrison S
- Publication year
- Publication venue
- Journal of immunology (Baltimore, Md.: 1950)
External Links
Snippet
We have constructed and obtained expression of a chimeric human-mouse immunoglobulin gene after transfection into mouse myeloma cells. A human VDJH gene segment was joined to a mouse C kappa gene in the plasmid vector pSV2-gpt, and the construct was transfected …
- 108091006028 chimera 0 title abstract description 25
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tan et al. | A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells. | |
EP0256654B1 (en) | Chimeric murine/human immunoglobulin specific for tumour-associated 17-1A Antigen | |
Liu et al. | Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity. | |
US5169939A (en) | Chimeric antibodies | |
Gillies et al. | High-level expression of chimeric antibodies using adapted cDNA variable region cassettes | |
Morrison | Transfectomas provide novel chimeric antibodies | |
EP0171496B1 (en) | Process for the production of a chimera monoclonal antibody | |
EP0173494A2 (en) | Chimeric receptors by DNA splicing and expression | |
US4978745A (en) | Immunoreactive heterochain antibodies | |
AU618990B2 (en) | Chimeric antibodies directed against human carcinoembryonic antigen | |
FI97303C (en) | Production of chimeric antibodies by homologous recombination | |
Zaller et al. | Deletion of a B-cell-specific enhancer affects transfected, but not endogenous, immunoglobulin heavy-chain gene expression. | |
US5807715A (en) | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin | |
Sharon et al. | Expression of a VHC κ chimaeric protein in mouse myeloma cells | |
Wood et al. | High level synthesis of immunoglobulins in Chinese hamster ovary cells. | |
AU618324B2 (en) | Bifunctional chimeric antibodies | |
Ruberti et al. | Cloning and expression of an anti-nerve growth factor (NGF) antibody for studies using the neuroantibody approach | |
Weidle et al. | Reconstitution of functionally active antibody directed against creatine kinase from separately expressed heavy and light chains in non-lymphoid cells | |
US5643749A (en) | Soluble interferon α-receptor, its preparation and use | |
EP0477739A2 (en) | Glycosyl-Phosphatidylinositol-Specific Phospholipase D | |
Newton et al. | Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice | |
Schneiderman et al. | Expression of 12 rabbit IgA C alpha genes as chimeric rabbit-mouse IgA antibodies. | |
WO1993001296A1 (en) | Antibody production in vaccinia virus infected cells | |
EP0404003A2 (en) | Chimeric mouse-human KM10 antibody with specificity to a human tumor cell antigen | |
Morrison et al. | Genetically engineered antibody molecules: new tools for cancer therapy |